ABSTRACT:
Patient safety is being identified more and more as a key priority for action that calls for a coordinated and group effort. Medication mistakes are the main reason people get hurt or hurt themselves in healthcare systems. The workforce at pharmacies, who are specialists in medications, is crucial in reducing prescription errors and addressing the global challenge of patient safety. The role of chemists in ensuring patient safety is critical. Pharmacists are responsible for ensuring that a patient won't suffer injury or die from taking a medication after receiving it and using it. The International Pharmaceutical Federation (FIP) acknowledges the crucial role pharm play in achieving regional, national, and global patient safety goals. The FIP collaborates with partners, stakeholders, and members from around the world to advocate for pharmacies' roles in advancing this global patient safety agenda and to imagine a world where people have safe access to healthcare and medications. Community pharmacy practise now include patient care services in addition to pharmaceutical product distribution. Similarly, optimising medicine and preventing adverse events during the whole drug use process need to be part of a community chemist's approach to patient safety, in addition to preventing errors during medication delivery. Community pharmacies have long struggled with connectivity to patient data and other healthcare providers, which has an impact on patient care delivery and safety. Three novel developments in connectedness in community pharmacy practise are shown here, which improve patient safety when community pharmacists provide patient care services during the whole medication use process.
Cite this article:
Palak Sharma, Munish Kumar, Diksha Sharma, Kapil Kumar Verma. A Review on Pharmacist Impact on patient safety. Asian Journal of Pharmacy and Technology. Tech. 2024; 14(1):87-4 doi: 10.52711/2231-5713.2024.00016
Cite(Electronic):
Palak Sharma, Munish Kumar, Diksha Sharma, Kapil Kumar Verma. A Review on Pharmacist Impact on patient safety. Asian Journal of Pharmacy and Technology. Tech. 2024; 14(1):87-4 doi: 10.52711/2231-5713.2024.00016 Available on: https://ajptonline.com/AbstractView.aspx?PID=2024-14-1-16
REFERENCES:
1. Cronenwett L, Sherwood G, Barnsteiner J, et al. Quality and Safety Education for Nurses. Outlook. 2007; 55:122–31.
2. Croskerry P, Wears RL, Binder LS. We are setting the educational agenda and curriculum for error prevention in emergency medicine. Acad Emerg Med. 2000; 7:1194–200.
3. Walton M, Woodward H, Staalduinen SV, et al. The WHO patient safety curriculum guide for medical schools. Qual Safe Health Care. 2010; 19: 542–6.
4. World Health Organization. Multi-professional Patient Safety Curriculum Guide. WHO Press, 2011.
5. Gurwich EL. Comparison of medication histories acquired by pharmacists and physicians. Am J Hosp Pharm. 1983; 40: 1541-2.
6. Pharmacists’ Impact on Patient Safety. American Pharmacists Association website. https://pharmacist.com/Portals/0/PD FS/Practice/Pharmacists Impact on Patient Safety. November 18. 2019.
7. Agency for Healthcare Research and Quality. (2016, December 9). AHRQ Tools To Reduce Hospital-Acquired Conditions. Retrieved from
8. Centers for Medicare & Medicaid Services. CMS Quality Reporting and Value-Based Programs & Initiatives. May 2022. Accessed June 28, 2022
9. Centers for Medicare & Medicaid Services. Hospital-Acquired Condition Reduction Program (HACRP). Accessed June 28, 2022
10. Dellit TH, Owens RC, McGowan Jr JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007; 44(2):159-77
11. Davey P, Marwick CA, Scott CL, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. The Cochrane Database of Systematic Reviews. 2017; 2: Cd003543.
12. Karanika S, Paudel S, Grigoras C, Kalbasi A, Mylonakis E. Systematic Review and Metaanalysis of Clinical and Economic Outcomes from the Implementation of Hospital-Based Antimicrobial Stewardship Programs. Antimicrobial Agents and Chemotherapy. 2016 Aug; 60(8):4840-52.
13. Salter C. Compliance and concordance during domiciliary medication review involving pharmacists and older people. Sociol Health Illn. 2010; 32: 21-36.
14. Schedlbauer A, Davies P, Fahey T. Interventions to improve adherence to lipid lowering medication. Cochrane Database Syst Rev. 2010; 3: CD004371.
15. Saini SD, Schoenfeld P, Kaulback K, Dubinsky MC. Effect of medication dosing on adherence in chronic diseases. Am J Manag Care. 2009.
16. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med. 2007; 167: 540-550.
17. Vermeire E, Wens J, Van Royen P, et al. Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005; 2: CD003638.
18. Carter BL, Foppe van Mil JL. Comparative effectiveness research: evaluating pharmacist interventions and strategies to improve medication adherence. Am J Hypertens. 2010; 23: 949-955.
19. Ma A, Chen DM, Chau FM, Saberi P. Improving adherence and clinical outcomes through an HIV pharmacist’s interventions. AIDS Care. 2010; 22: 1189-1194.
20. Touchette D. Improving adherence in the community and clinic pharmacy settings: an emerging opportunity. Pharmacotherapy. 2010; 30:425-427.
21. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008; 10: 348-354.
22. Tsiantou V, Pantzou P, Pavi E, et al. Factors affecting adherence to antihypertensive medication in Greece: results from a qualitative study. Patient Prefer Adherence. 2010; 4: 335-343.
23. Ahmad A, Hugtenburg J, Welschen LM, et al. Effect of medication review and cognitive behavior treatment by community pharmacists of patients discharged from the hospital on drug-related problems and compliance: design of a randomized control trial. BMC Public Health. 2010; 10: 133.
24. Kripalani S, Robertson R, Love-Ghaffari MH, et al. Development of an illustrated medication schedule as a low-literacy patient education tool. Patient Educ Couns. 2007; 66: 368-377.
25. Chisholm-Burns MA, Kim Lee J, Spivey CA, et al. US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Medical Care. 2010; 48:923-933. Morgado MP, Morgado SR, Mendes LC, et al. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: review and meta-analysis. Am J Health Syst Pharm. 2011; 68: 241-253.
26. Thompson CA. New healthcare laws will bring changes for pharmacists. Am J Health Syst Pharm. 2010; 67:690-695.
27. Altmiller G. The role of constructive feedback in patient safety and continuous quality improvement. Nurs Clin North Am. 2012; 47(3): 365-74.
28. Karanika S, Paudel S, Grigoras C, Kalbasi A, Mylonakis E. Systematic Review and Meta-analysis of Clinical and Economic Outcomes from the Implementation of Hospital-Based Antimicrobial Stewardship Programs. Antimicrobial agents and chemotherapy. 2016; 60(8): 4840-52. doi: 10.1128/AAC.00825-16.
29. Harkness, Turna L. MSN, RN, LGBC. Effective care coordination and transition management for older adults. Nursing Made Incredibly Easy. 2020; 18(5): 26-32.
30. National Transitions of Care Coalition Measures Work Group, (Transitions of Care Measures) Washington DC: National Transitions of Care Coalition; 2008.
31. Saleh SS, Freire C, Morris‐Dickinson G, Shannon T. An Effectiveness and Cost‐Benefit Analysis of a Hospital‐Based Discharge Transition Program for Elderly Medicare Recipients. Journal of the American Geriatrics Society. 2012.
32. Karanika S, Paudel S, Grigoras C, Kalbasi A, Mylonakis E. Systematic Review and Meta-analysis of Clinical and Economic Outcomes from the Implementation of Hospital-Based Antimicrobial Stewardship Programs. Antimicrobial Agents and Chemotherapy. 2016.
33. Baur D, Gladstone BP, Burkert F, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. The Lancet Infectious Diseases. 2017.